Status:
NOT_YET_RECRUITING
The Effect of Laughter Yoga in Beta Thalassaemia Major Patients: a Randomised Controlled Trial
Lead Sponsor:
Ataturk University
Conditions:
Beta Thalassemia Major
Thalassemia Majors (Beta-Thalassemia Major)
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The aim of this study was to evaluate the effects of laughter yoga on Fatigue, Depression-Anxiety-Stress, Sleep quality, Haematological values and Blood transfusion number in Beta Thalassemia Major pa...
Detailed Description
Beta Thalassaemia Major patients require regular transfusions at an early age due to severe anaemia. These frequent blood transfusions, which are necessary to manage anaemia in Beta Thalassaemia Major...
Eligibility Criteria
Inclusion
- Diagnosed with Beta Thalassaemia major,
- Over 18 years of age,
- No hearing and communication problems,
- The one with the smartphone
- Routine treatment with iron chelators, folic acid and magnesium
- Do not have a physical problem that will prevent yoga exercises (bleeding haemorrhoids, all kinds of hernia, persistent cough, incontinence, severe back pain, hypertension, major psychiatric diseases, pregnancy, flu, epilepsy, surgery in the last 3 months, etc.)
- Depression-Anxiety-Stress scale scores of 10 and above for depression (depressed), 8 and above for anxiety (anxious), 15 and above for stress (stressed)
- Beta thalassaemia major patients who volunteered to participate in the study will be included in the study sample
Exclusion
- Who doesn't practice laughter yoga
- Changing the treatment regime
- Patients who wish to withdraw from the study
Key Trial Info
Start Date :
June 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06980662
Start Date
June 1 2025
End Date
August 31 2025
Last Update
May 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Batman Training and Research Hospital
Batman, Turkey (Türkiye), 72000